Drug recall · October 23, 2019
Leucovorin Calcium Injection recall
Why: Crystallization: Presence of particulate matter identified as API crystallization
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 Rx Only Ingenus Pharmaceuticals, LLC. Orlando, FL 32839
- Lots / codes
Lot#: 18048, 18049 Exp. 04/2020; 18050 Exp 05/2020; 19036 Exp 12/2020
- Quantity
- 16485 vials
- Company
- Ingenus Pharmaceuticals Llc, Orlando, FL
- Distribution
- U.S.A. Nationwide
- Initiated
- October 9, 2019 · Voluntary: Firm initiated
- Classified
- October 17, 2019
- Reported
- October 23, 2019
- Ended
- December 1, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Leucovorin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.